您的当前位置:首页 > 行业数据 > PD1xVEGF双抗全球3期临床
图片属性
图片格式:PNG 图片大小:310KB 图片尺寸:3813*1415
同报告图片
 / 4
PD1xVEGF双抗全球3期临床_第1页
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
PD1xVEGF双抗全球3期临床_第2页
PD1xVEGF双抗全球3期临床_第3页
PD1xVEGF双抗全球3期临床_第4页
PD1xVEGF双抗全球3期临床_第5页
所属报告: 医药生物行业2026年投资策略:关注创新出海重视新技术方向-260126(70页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠